Using a biodegradable polymer produced by a slime mold, a team of investigators from Cedars-Sinai Medical Center has created a multifunctional nanoparticle that attacks a key pathway involved in breast cancer in two different ...
Bio & Medicine
Mar 28, 2011
0
0
A new study suggests that combining two experimental anticancer peptide agents might simultaneously block formation of new tumor blood vessels while also inhibiting the growth of tumor cells.
Biochemistry
Mar 14, 2011
0
0
Ongoing clinical trials have shown that a peptide known as PHSCN can slow or prevent the spread of metastatic breast cancer in over a third of patients treated with the drug. This drug works by binding to an activated receptor ...
Bio & Medicine
Jan 19, 2011
0
0
Researchers at Rice University, collaborating with investigators at the Baylor College of Medicine, have used two different types of imaging technologies to track the delivery of a therapeutic nanoparticle to breast tumors. ...
Bio & Medicine
Dec 17, 2010
0
0
(PhysOrg.com) -- To improve the tumor-specific delivery of drug to tumors, a team of investigators from the University of California, San Diego (UCSD) has created a system of nanoparticles-within-a-nanoparticle that can be ...
Bio & Medicine
Nov 25, 2010
1
0
Researchers at the University of Illinois at Chicago College of Medicine have found how gene expression that may contribute to drug resistance is ramped up in unusual types of breast tumors. Their findings may offer new therapy ...
Biochemistry
Oct 8, 2010
0
0
One of the first chemotherapy drugs given to patients diagnosed with cancer — especially lung, ovarian or breast cancer — is cisplatin, a platinum-containing compound that gums up tumor cells’ DNA. Cisplatin does a ...
Bio & Medicine
Jul 28, 2010
9
0
You can teach an old drug new chemotherapy tricks. Northwestern University researchers took a drug therapy proven for blood cancers but ineffective against solid tumors, packaged it with nanotechnology and got it to combat ...
Bio & Medicine
Jul 15, 2010
0
0
Scientists at Dana-Farber Cancer Institute have found a way to disable a common protein that often thwarts chemotherapy treatment of several major forms of cancer.
Biochemistry
Jun 20, 2010
0
0
(PhysOrg.com) -- Recent studies support the idea that the standard methods of screening men for prostate cancer leave much to be desired, particularly in terms of their inability to have much effect on prostate cancer survival.
Bio & Medicine
May 25, 2010
0
0
